Trust Company of the Ozarks’s Bristol-Myers Squibb BMY Stock Holding History

Trust Company of the Ozarks’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.39M	Sell	23,487 -550	-2%	-$34.9K	0.48%	47
2015 Q2	$1.6M	Sell	24,037 -10	-0%	-$659	0.44%	42
2015 Q1	$1.55M	Sell	24,047 -85	-0.4%	-$5.32K	0.41%	42
2014 Q4	$1.43M	Sell	24,132 -400	-2%	-$22.6K	0.4%	49
2014 Q3	$1.25M	Sell	24,532 -100	-0.4%	-$5K	0.35%	55
2014 Q2	$1.2M	Sell	24,632 -700	-3%	-$34.5K	0.32%	57
2014 Q1	$1.32M	Buy	25,332 +225	+0.9%	+$12K	0.37%	45
2013 Q4	$1.33M	Sell	25,107 -1,850	-7%	-$94.2K	0.38%	45
2013 Q3	$1.25M	Buy	26,957 +400	+2%	+$17.6K	0.39%	49
2013 Q2	$1.19M	Buy	+26,557	New	+$1.15M	0.39%	51

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Trust Company of the Ozarks's BMY Position: Q3 2015 in Review

Trust Company of the Ozarks reduced its Bristol-Myers Squibb (BMY) stake by 2.3% in Q3 2015, selling an estimated $34.9K and leaving 23,487 shares worth $1.39M. The position accounts for 0.48% of the portfolio, ranked #47.

Trust Company of the Ozarks first reported a position in BMY in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.6M in Q2 2015. 1,454 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

Trust Company of the Ozarks held 23,487 shares of Bristol-Myers Squibb worth $1.39M as of Q3 2015.
Trust Company of the Ozarks sold 550 Bristol-Myers Squibb shares in Q3 2015, an estimated $34.9K.
Bristol-Myers Squibb made up 0.48% of Trust Company of the Ozarks's portfolio in Q3 2015, its #47 holding.
Trust Company of the Ozarks first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 10 quarters since.
Trust Company of the Ozarks's Bristol-Myers Squibb position peaked at $1.6M in Q2 2015.
1,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on Trust Company of the Ozarks's 13F filing for Q3 2015, filed 4 Nov 2015.